Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Brain Changes in Alzheimer’s Disease Using Flortaucipir (18F) for Patients with Alzheimer’s and Its Variants

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    France
  • Study of [18F]MC225 to Assess P-glycoprotein Function in Patients with Alzheimer’s, Mild Cognitive Impairment, and Parkinson’s Disease

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    The Netherlands
  • Study on the Safety of Dasatinib and Quercetin for Patients with Mild Cognitive Impairment or Early Alzheimer’s Disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on the Effects of Sabirnetug for Patients with Early Alzheimer’s Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    France Germany Spain
  • Study on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer’s Disease

    Not yet recruiting

    2 1
    Czechia France Germany Italy The Netherlands Poland +1
  • Study on the Safety and Effects of Hydroxypropylbetadex Infusions in Patients with Early Alzheimer’s Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany
  • Study on BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Belgium Czechia Denmark Finland France Germany +5
  • Study on JNJ-64042056 for Preclinical Alzheimer’s Disease in Patients

    Not yet recruiting

    2 1
    Investigated Diseases:
    Belgium France Germany Spain Sweden
  • Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer’s Dementia Patients

    Not recruiting

    3 1
    Investigated Diseases:
    Bulgaria Denmark Estonia Germany Greece Poland +1
  • Study on the Safety and Effects of BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia

    Not recruiting

    2 1 1
    Investigated Diseases:
    Belgium Czechia Denmark Finland France Germany +5